Literature DB >> 19927008

Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.

Zuzana Husková1, Zdenka Vanourková, Michaela Erbanová, Monika Thumová, Martin Opocenský, John J Mullins, Herbert J Kramer, Marcela Bürgelová, Ludek Cervenka.   

Abstract

OBJECTIVE: We evaluated the effects of salt restriction and of increasing dietary salt loading on blood pressure and the renin-angiotensin system in transgenic rats with inducible hypertension.
METHODS: Hypertension was induced in Cyp1a1-Ren-2 rats through dietary administration of the natural xenobiotic indole-3-carbinol (0.3%), which activates the renin gene. Rats were fed either a normal-salt diet (0.6% NaCl), three different high-salt diets (2, 4 and 8% NaCl) or a low-salt diet (<0.04% NaCl). Blood pressure was monitored by radiotelemetry. Angiotensin II (ANG II) levels were determined by radioimmunoassay.
RESULTS: Induction of the renin gene by administration of indole-3-carbinol resulted in normal-salt diet fed animals in the development of severe hypertension that was accompanied by marked increases in plasma and kidney ANG II levels. Feeding the low-salt diet substantially attenuated the development of hypertension. Treatment with the 2 and 4% high-salt diet did not worsen the course of hypertension and did not alter ANG II levels when compared with rats on the normal salt diet. Feeding the 8% high-salt diet exacerbated the course of hypertension and was associated with further strong increases in plasma and kidney ANG II levels.
CONCLUSION: Our results demonstrate that after induction of the renin gene in Cyp1a1-Ren-2 transgenic rats inappropriate increases in plasma and kidney ANG II levels in response to very high dietary salt intake are responsible for the development of severe hypertension in this model of inducible renin transgenic rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19927008     DOI: 10.1097/HJH.0b013e3283345d69

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.

Authors:  Zuzana Honetschlägerová; Zuzana Husková; Zdeňka Vaňourková; Alexandra Sporková; Herbert J Kramer; Sung Hee Hwang; Hsing-Ju Tsai; Bruce D Hammock; John D Imig; Luděk Červenka; Libor Kopkan
Journal:  J Physiol       Date:  2011-01-01       Impact factor: 5.182

2.  Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.

Authors:  L Červenka; V Melenovský; Z Husková; A Sporková; M Bürgelová; P Škaroupková; S H Hwang; B D Hammock; J D Imig; J Sadowski
Journal:  Physiol Res       Date:  2015-06-05       Impact factor: 1.881

3.  Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats.

Authors:  Zuzana Honetschlägerová; Alexandra Sporková; Libor Kopkan; Zuzana Husková; Sung H Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Petr Kujal; Zdenka Vernerová; Věra C Chábová; Vladimír Tesař; Luděk Cervenka
Journal:  J Hypertens       Date:  2011-08       Impact factor: 4.844

4.  Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.

Authors:  Dinko Susic; Edward D Frohlich; Hiroyuki Kobori; Weijian Shao; Dale Seth; L Gabriel Navar
Journal:  J Hypertens       Date:  2011-04       Impact factor: 4.844

Review 5.  Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.

Authors:  Dewan S A Majid; Minolfa C Prieto; Luis Gabriel Navar
Journal:  Curr Hypertens Rev       Date:  2015

6.  Expressions of per1 clock gene and genes of signaling peptides vasopressin, vasoactive intestinal peptide, and oxytocin in the suprachiasmatic and paraventricular nuclei of hypertensive TGR[mREN2]27 rats.

Authors:  Zuzana Dzirbíková; Alexander Kiss; Monika Okuliarová; Libor Kopkan; Ludĕk Cervenka
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

7.  Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Authors:  Šárka Jíchová; Libor Kopkan; Zuzana Husková; Šárka Doleželová; Jan Neckář; Petr Kujal; Zdenka Vernerová; Herbert J Kramer; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Rami N Reddy; John R Falck; John D Imig; Luděk Červenka
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

8.  Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.

Authors:  Zuzana Honetschlägerová; Kento Kitada; Zuzana Husková; Alexandra Sporková; Libor Kopkan; Marcela Bürgelová; Šárka Varcabová; Akira Nishiyama; Sung Hee Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

9.  Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.

Authors:  Alexandra Sporková; Sárka Jíchová; Zuzana Husková; Libor Kopkan; Akira Nishiyama; Sung H Hwang; Bruce D Hammock; John D Imig; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Herbert J Kramer; Luděk Cervenka
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-12       Impact factor: 2.557

10.  Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.

Authors:  Vicky F Rands; Dale M Seth; Hiroyuki Kobori; Minolfa C Prieto
Journal:  Gend Med       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.